A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult

• Main Authors: Thundon Ngamprasertchai (Author), Chayanis Kositamongkol (Author), Saranath Lawpoolsri (Author), Pinyo Rattanaumpawan (Author), Viravarn Luvira (Author), Piriyaporn Chongtrakool (Author), Jaranit Kaewkungwal (Author), Kulkanya Chokephaibulkit (Author), Pochamana Phisalprapa (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

IntroductionThis study aims to assess the economic impact of introducing the 13-valent pneumococcal conjugate vaccine (PCV13) and 23-valent pneumococcal polysaccharide vaccine (PPSV23) to Thai older adult aged ≥ 65  years who are healthy or with chronic health conditions and immunocompromised condit...